Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
1998-01-14
2001-04-24
Chan, Christina Y. (Department: 1644)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S071100, C435S252300, C435S320100, C435S455000, C435S471000, C536S023100, C536S023500
Reexamination Certificate
active
06221629
ABSTRACT:
BACKGROUND OF THE INVENTION
Mature B cells comprise 10 to 15 percent of human peripheral blood lymphocytes, 50 percent of splenic lymphocytes, and approximately 10 percent of bone marrow lymphocytes. Mature B cells are derived from bone marrow precursor cells that arise continuously throughout life. B cells express on their surface intramembrane immunoglobulin (Ig) molecules that function as B cell antigen receptors in a complex of Ig-associated à and
signaling molecules with intracellular signaling events. B cells also express surface receptors for the Fc region of IgG molecules as well as receptors for activated complement components. The primary function of B cells is to produce antibodies.
B cells undergo several selection steps during differentiation from immature cells to mature B cells or antibody-secreting cells. Only B cells which have undergone the selection process join the mature B cell pool and differentiate into antibody secreting cells upon stimulation. These selections allow for maintenance of a stable B cell pool without the production of autoreactive B cells which react to create an autoimmune response and efficient antibody production with adequate specificity and affinity. von Boehmer, H. Cell 1994 76:210; Liu et al. Immunol. Today 1992 13:17; Liu et al. Nature (Lond.) 1989 342:929. The selection steps involve apoptosis, survival or proliferation of B cells. A study in double transgenic mice revealed that apoptosis is important in the negative selection that destroys B cells bearing aberrant specificity against self-antigens. Hartley et al. Cell 1993 72:325. The autoantigen itself or the autoantigen in combination with other signals triggered apoptosis in these hazardous cells. In contrast, positive selection requires a condition where only cells receiving a signal are able to survive and grow. Otherwise, cells undergo apoptosis. In the germinal center, only cells bearing a surface immunoglobulin with sufficient affinity against an antigen are allowed to survive and grow. Liu et al. Immunol. Today 1992 13:17. In this situation, stimulatory signals such as the antigen itself or the CD40 ligand are shown to protect cells from apoptosis and induce survival or proliferation. Liu et al. Immunol. Today 1992 13:17; Liu et al. Nature (Lond.) 1989 342:929. Thus, apoptosis plays an essential role in the selection process. A signal that is capable of inducing or blocking apoptosis has been implicated as a pivotal system for selecting B cells.
Lymphocytes such as B cells are one of the most sensitive cells to immediate radiation induced damage. Anderson, R. E., and Warner, N. L. Adv. Immunol. 1976 24:215. Quiescent lymphocytes have been found to be more sensitive than actively cycling cells. The damaged cells are believed to undergo apoptosis. This process, which does not involve cell division, is sometimes referred to as interphase death. It has been hypothesized that lymphocyte signaling systems which are important in facilitating the B cell selection process are also related to cell death by irradiation.
Miyake et al. J. Exp. Med. 1994 180:1217-1224 disclose a monoclonal antibody, RP/14, that protects murine B cells from apoptosis induced by irradiation or dexamethasone. A molecule recognized by this antibody was found to be expressed on the murine B cells. This murine B cell surface molecule, referred to as RP105, has been further characterized. Miyake et al. J. Immunol. 1995 154:3333-3340. RP105 is a murine B cell antigen. It is monomeric, with a size of approximately 105 kDa. It is expressed on mature B cells, but not on either immature or pre-B cells. This antigen is believed to transmit a signal into murine B cells that results in protection from radiation or dexamethasone induced apoptosis.
The N-terminal amino acid sequence of the murine RP105 molecule has been determined. A cDNA clone was also isolated with a probe corresponding to the obtained amino acid sequence. DNA sequencing revealed that an encoded murine polypeptide is a type 1 transmembrane protein consisting of 641 amino acids in a mature form. Northern hybridization with the clone detected a transcript of approximately 3 kb. This transcript was found in mouse spleen, but not thymus, kidney, muscle, heart, brain or liver. Transfection of the clone into a pro-B cell line resulted in the expression of RP105.
A computer search showed similarity of murine RP105 to a number of molecules including decorin and biglycan, which are human proteoglycans in extracellular tissue; the Drosophila toll, tartan, connectin, chaoptin and slit proteins (which are responsible for dorsal/ventral polarity, epidermal/subepidermal structure, target recognition of a subset of motor neurons, photoreceptor morphogenesis and pathway finding by commissural axons during embryogenesis); and the à-subunit of platelet glycoprotein Ib (involved in platelet adhesion to vascular endothelial cells). Miyake et al. J. Immunol. 1995 154:3333-3340. The property shared by murine RP105 and these molecules is tandem repeats of a leucine-rich motif (LRM) These repeated motifs are observed in members of the leucine-rich repeat protein family and have been implicated in protein-protein interactions such as cell adhesion or receptor-ligand binding. The murine RP105 molecule has 22 tandem repeats of a leucine-rich motif, as well as amino and carboxyl flanking regions that are characteristically conserved among members of this family. Thus, murine RP105 is believed to be a member of the leucine-rich repeat family and the first one that is expressed specifically on mature B cells.
A human gene encoding a novel human B cell surface molecule has now been found.
SUMMARY OF THE INVENTION
An object of the present invention is to provide isolated nucleic acid molecules encoding a novel human B cell surface molecule human including mRNAs, DNAs, cDNAs, genomic DNAs as well as analogs and biologically active and diagnostically or therapeutically useful fragments thereof.
Another object of the present invention is to provide a polypeptide which is a novel human B cell surface molecule, as well as biologically active and diagnostically or therapeutically useful fragments, analogs and derivatives thereof.
Another object of the present invention is to provide antibodies or receptor bodies against this polypeptide.
Another object of the present invention is to provide a process for producing this polypeptide by recombinant techniques comprising culturing recombinant prokaryotic and/or eukaryotic host cells, containing a human nucleic acid sequence for the novel human B cell surface molecule under conditions promoting expression of this polypeptide and subsequent recovery of this polypeptide.
These and other aspects of the present invention should be apparent to those skilled in the art from the teachings herein.
DETAILED DESCRIPTION OF THE INVENTION
A gene encoding an antigen on human B cells involved in B cell proliferation and protection from dexamethasone- and irradiation-induced apoptosis has now been found. The nucleotide sequence of this gene has been determined and is provided as SEQ ID NO: 1. A plasmid containing the cDNA clone for this novel human B cell surface molecule was deposited as ATCC Deposit No. 69902.
The cDNA for this novel human B cell surface molecule is 2775 bp in length. It is 71.9% identical to murine RP105 at the nucleotide level. Nucleotide 140 through 2092 of the cDNA encode an open reading frame of 651 amino acids, similar in size to mouse RP105 (662 amino acids). The translated polypeptide from the open reading frame of the human cDNA is 73.1% identical to murine RP105 with the leucine-rich repeats being conserved.
The present invention further relates to polypeptides encoded by the cDNA clone of this human B cell surface molecule as well as fragments, analogs and derivatives of such polypeptides. The terms “fragment,” “derivative” and “analog” when referring to the polypeptides encoded by the deposited cDNA, means a polypeptide which retains essentially the same biological function or activity. Thus, an analog includes a proprotei
Marshall Lisa A.
Roshak Amy K.
Chan Christina Y.
Gambel Phillip
Han William T.
King William T.
Ratner & Prestia
LandOfFree
Expression vectors and process for producing human B cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expression vectors and process for producing human B cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expression vectors and process for producing human B cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2492358